Skip to main content
. 2019 Sep 8;2019:1089107. doi: 10.1155/2019/1089107

Table 3.

Receiver operating characteristic curve analysis of 28 cytokines for diagnosis of sepsis.

Biomarkers AUC Cut-off Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Accuracy (95% CI)
IFN-α 0.531 1.0 7.5 (5.8-9.1) 98.8 (98.1-99.4) 86.2 (40.5-62.7) 51.6 (40.5-62.7) 53.2 (44.7-61.5)
IFN-γ 0.556 1.0 11.3 (9.3-13.2) 100 (99.9-100) 100 (99.9-100) 0.10 (3.4-16.8) 19.3 (12.6-26.1)
IL-1RA 0.893 581.6 80.1 (77.6-82.5) 92.5 (90.8-94.1) 91.4 (84.2-98.5) 82.2 (73.8-90.7) 86.3 (80.5-92.1)
IL-1β 0.598 1.9 27.5 (24.7-30.2) 96.3 (95.1-97.4) 88.1 (79.8-96.3) 43.1 (46.1-68.1) 61.9 (53.7-70.1)
IL-1α 0.672 1.4 47.4 (44.3-50.4) 87.5 (85.4-89.5) 79.1 (68.7-89.5) 62.4 (51.7-73.2) 67.4 (59.5-75.3)
IL-2 0.583 1.0 75.0 (72.3-77.6) 38.8 (35.8-41.8) 55.1 (42.3-67.7) 60.8 (49.9-71.6) 56.9 (48.5-62.5)
IL-4 0.556 1.0 11.3 (9.3-13.2) 100 (99.9-100) 100 (99.9-100) 52.9 (41.9-64.1) 55.6 (47.2-64.1)
IL-5 0.575 1.0 15.1 (12.8-17.3) 100 (99.9-100) 100 (99.9-100) 54.1 (43.0-65.1) 57.6 (59.2-65.9)
IL-6 0.830 40.8 67.5 (64.5-70.4) 95.5 (94.2-96.8) 93.7 (87.6-99.9) 74.6 (64.9-84.2) 81.5 (74.9-88.1)
IL-7 0.707 3.2 57.5 (54.4-60.5) 85.1 (82.8-87.3) 79.4 (69.1-89.7) 66.7 (56.2-77.1) 71.3 (63.7-78.9)
IL-8 0.781 11.2 71.3 (68.4-74.1) 81.3 (78.8-83.7) 79.2 (68.8-89.6) 73.9 (64.1-83.4) 76.3 (69.1-83.4)
IL-9 0.519 1.0 3.8 (2.6-4.9) 100 (99.9-100) 100 (99.9-100) 50.9 (39.8-62.1) 51.9 (43.4-60.3)
IL-10 0.820 1.0 65.1 (62.1-68.1) 97.5 (96.5-98.5) 96.3 (91.4-100) 73.6 (63.8-83.4) 81.3 (74.7-87.9)
IL-12 0.506 1.0 2.5 (1.5-3.5) 98.7 (97.9-99.4) 65.7 (53.6-77.8) 50.3 (39.2-61.4) 50.6 (42.2-59.1)
IL-13 0.606 10.5 21.3 (18.7-23.8) 100 (99.9-100) 100 (99.9-100) 55.9 (44.9-66.9) 60.6 (52.4-68.8)
IL-15 0.513 24.7 25.0 (22.1-27.3) 91.3 (89.5-93.0) 73.9 (62.7-85.1) 54.8 (43.7-65.8) 58.0 (49.6-66.3)
IL-17A 0.641 2.15 42.5 (39.4-45.6) 88.8 (86.8-90.7) 79.1 (68.7-89.5) 60.7 (49.8-71.5) 65.7 (57.6-73.6)
IL-18 0.746 1.0 53.8 (50.7-56.8) 92.5 (90.8-94.1) 87.7 (79.4-96.1) 66.7 (56.2-77.1) 73.1 (65.6-80.6)
IL-21 0.685 1.0 23.8 (21.1-26.4) 92.5 (90.8-94.1) 76.0 (65.1-86.9) 54.8 (43.7-65.8) 58.1 (49.8-66.4)
IL-22 0.615 1.0 28.7 (25.8-31.5) 93.8 (92.3-95.2) 82.2 (72.4-91.9) 56.8 (45.8-67.8) 61.2 (53.0-69.4)
IL-23 0.601 1.0 22.5 (19.9-25.1) 97.5 (96.5-98.4) 90.0 (82.3-97.6) 55.7 (44.6-66.7) 60.0 (51.7-68.2)
IL-27 0.613 1.0 23.8 (21.1-26.4) 98.7 (97.9-99.4) 94.8 (89.1-100) 56.4 (45.4-67.4) 61.2 (53.0-69.4)
IL-31 0.575 1.0 16.5 (14.1-18.8) 98.8 (98.1-99.4) 93.2 (86.8-99.6) 54.2 (43.1-65.2) 57.6 (49.3-65.9)
LIF 0.760 6.1 78.8 (76.2-81.3) 62.5 (59.4-65.5) 67.7 (55.8-79.6) 74.7 (65.0-84.2) 70.6 (62.9-78.3)
GM-CSF (CSF2) 0.519 1.0 3.8 (2.6-4.9) 100 (99.0-100) 100 (99.0-100) 50.9 (39.8-62.0) 51.9 (43.5-60.3)
SCF (KITLG) 0.721 14.8 60.1 (57.1-63.1) 77.5 (74.9-80.1) 72.7 (61.4-84.1) 66.0 (55.5-76.5) 68.8 (60.9-76.6)
TNF-α (LTA) 0.531 1.0 15.1 (12.8-17.3) 91.3 (89.5-93.0) 63.4 (51.2-75.7) 51.8 (40.7-62.9) 53.2 (44.7-61.6)
TNF-β (LTB) 0.513 1.0 2.5 (1.5-3.4) 100 (99.0-100) 100 (99.0-100) 50.6 (39.5-61.7) 51.3 (42.8-59.6)

AUC: area under receiver operating characteristic curve; PPV: positive predictive value; NPV: negative predictive value: CI; confidence intervals; IFN: interferon; IL: interleukin; LIF: leukemia inhibitory factor; TNF: tumor necrosis factor; GM-CSF: granulocyte macrophage colony stimulating factor; SCF: stem cell factor.